Potentiometric ion determinations using enhanced selectivity asymmetric ion-selective membranes

• US 5,531,870 A
• Filed: 05/05/1995
• Issued: 07/02/1996
• Est. Priority Date: 12/21/1992
• Status: Expired due to Term

• Current Assignee: Siemens Healthcare Diagnostics Incorporated (Siemens AG)
• Original Assignee: E. I. du Pont de Nemours and Company (Corteva, Inc.)
• Inventors: Cha, Geun Sig
• Primary Examiner(s): Bell, Bruce F.
• Application Number:
  US08/437,117
• Time in Patent Office: 424 Days
• Field of Search: 204/153.12, 204/153.21, 204/403, 204/415, 204/416, 204/418, 204/435, 435/817, 435/291, 435/288
• US Class Current: 205/778
• CPC Class Codes: G01N 27/3335 the membrane containing at least one organic component G01N27/3271 takes precedence; aspects concerning the enzyme reagent in enzyme electrodes C12Q1/001
• CPC Class Codes: Y10S 435/817 Enzyme or microbe electrode

Abstract

This invention relates to a process for performing enhanced selectivity potentiometric ion determinations using an asymmetric ion membrane electrode having an asymmetric membrane with a hydrophilic layer fused to an ion-selective layer.

Claims

1. A process for performing potentiometric ion determinations on biological samples using an ion selective asymmetric membrane electrode and a reference electrode electrolytically connected to the ion-selective asymmetric membrane electrode which comprises:

(a) contacting a biological sample suspected of containing an ion of interest with the ion-selective asymmetric membrane electrode, the ion-selective asymmetric membrane electrode having an asymmetric membrane with an ion selective layer and a hydrophilic layer fused to the ion-selective layer, the ion-selective layer containing an ion-selective agent and a plasticizing agent, the hydrophilic layer being in contact with the sample,

(b) measuring the potential difference between the ion-selective asymmetric membrane electrode and the reference electrode; and

(c) relating the potential difference to the concentration of the ion of interest in the sample, thereby enhancing potentiometric ion selectivity.

2. A method of using a potentiometric, ion-selective, asymmetric membrane electrode to enhance potentiometric ion selectivity for an ion of interest selected from the group consisting of Cl^-, CO₃^2-, and Li⁺ and to decrease interferences from an interfering ion during the assay of a sample, the method comprising:

(a) contacting a biological sample with the asymmetric, ion-selective membrane which is in contact within the electrode with a conductor, the asymmetric membrane comprising

     1) an ion-selective layer comprising a polymer, an ion-selective agent and a plasticizing agent and

     2) a hydrophilic layer fused to the ion-selective layer wherein the hydrophilic layer is in direct contact with the diluted sample;

(b) measuring the potential difference between the potentiometric, ion-selective, asymmetric membrane electrode and a reference electrode electrolytically connected to the ion-selective asymmetric membrane electrode in a non-equilibrium or an equilibrium mode; and

(c) relating the potential difference to the concentration of the ion chosen in the sample, thereby enhancing potentiometric ion selectivity.

3. The method of claim 2 wherein the potential difference is measured kinetically.

4. The method of claim 2 wherein prior to step (a) the biological sample is diluted.

5. The process of claim 4 wherein the biological sample is diluted with a buffer solution such that the concentration of the interfering substance is less than about 2×

10^-3 M and the pH of the diluted sample is about 7.5 to 9.5.

6. The method of claim 5 wherein the asymmetric, ion-selective electrode membrane is selective for carbonate ion.

7. The method of claim 2 wherein the conductor is selected from the group consisting of carbon, metal, and metal/metal salt.

8. The method of claim 2 wherein an electrolyte is positioned between and in contact with the conductor and the membrane.

9. The method of claim 2 wherein the hydrophilic layer contains hydroxyl groups.

10. The method of claim 2 wherein the hydrophilic layer is selected from the group consisting of partially hydrolyzed cellulose, cellulose ester, poly(vinyl acetate), polyurethane, cellulose, poly(vinyl butyral), poly(vinyl alcohol), poly(vinyl chloride), and copolymers of vinyl chloride.

11. The method of claim 2 wherein the polymer of the ion-selective layer is selected from the group consisting of cellulose, cellulose ester, poly(vinyl acetate), polyurethane, cellulose, poly(vinyl butyral), poly(vinyl alcohol), poly(vinyl chloride), and copolymers of vinyl chloride.

12. The method of claim 2 wherein the ion-selective agent comprises an ionophore, an ion-complexing agent, or a combination of an ionophore and an ion-complexing agent.

13. The method of claim 12 wherein the ionophore comprises a derivative of trifluoroacetophenone.

14. The method of claim 12 wherein the ion-complexing agent is selected from the group consisting of tridodecylmethylammonium chloride, methytricaprylammonium chloride, tetraoctylammonium bromide, and methyltrioctadecyl ammonium bromide.

15. The method of claim 2 wherein the ion-selective agent is a metalloporphyrin.

16. The method of claim 2 wherein the plasticizing agent is selected from the group consisting of bis(2-ethylhexyl) sebacate, bis(2-ethylhexyl)adipate, bis(2-ethyl hexyl)phthalate, dicapryl adipate, dipentyl phthalate, dibutyl sebacate, and 2-nitrophenyloctyl ether.

17. The method of claim 2 wherein the biological sample is selected from the group consisting of serum, urine, cerebrospinal fluid, amniotic fluid, plasma, whole blood, saliva, and tears.

18. The method of claim 2 wherein the biological sample contains an interfering substance.

19. The method of claim 18 wherein the interfering substance is selected from the group consisting of salicylate, para-amino salicylate, gentisate, and a combination thereof.